Search Results - "Boparai §, Navdeep"

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection by Bacon, Bruce R, Gordon, Stuart C, Lawitz, Eric, Marcellin, Patrick, Vierling, John M, Zeuzem, Stefan, Poordad, Fred, Goodman, Zachary D, Sings, Heather L, Boparai, Navdeep, Burroughs, Margaret, Brass, Clifford A, Albrecht, Janice K, Esteban, Rafael

“…In this trial involving patients infected with hepatitis C virus (HCV) genotype 1 in whom previous treatment had failed, boceprevir plus peginterferon and…”
Get full text

Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection by KALLMAN, Jillian, O'NEIL, Mary Margaret, LARIVE, Brett, BOPARAI, Navdeep, CALABRESE, Leonard, YOUNOSSI, Zobair M

“…In addition to chronic hepatitis, many individuals infected with hepatitis C virus (HCV) suffer from fatigue, which may compromise their health-related quality…”
Get full text

Posaconazole for the Treatment of Azole-Refractory Oropharyngeal and Esophageal Candidiasis in Subjects with HIV Infection by Skiest, Daniel J., Vazquez, Jose A., Anstead, Gregory M., Graybill, John R., Reynes, Jacques, Ward, Douglas, Hare, Roberta, Boparai, Navdeep, Isaacs, Randi

“…Background. We evaluated the efficacy and safety of oral posaconazole for human immunodeficiency virus (HIV)–infected subjects with oropharyngeal candidiasis…”
Get full text

Hepatic iron and nonalcoholic fatty liver disease by Younossi, Zobair M., Gramlich, Terry, Bacon, Bruce R., Matteoni, Christi A., Boparai, Navdeep, O'Neill, Rosemary, McCullough, Arthur J.

“…Increased iron is suspected to enhance hepatic injury associated with nonalcoholic fatty liver disease (NAFL). We evaluated the impact of iron accumulation on…”
Get full text

Cholestatic liver diseases and health-related quality of life by Younossi, Zobair M, Kiwi, Michelle L, Boparai, Navdeep, Price, Lori Lyn, Guyatt, Gordon

“…Symptoms associated with primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) negatively affect health-related quality of life (HRQL). The…”
Get full text

Boceprevir for Untreated Chronic HCV Genotype 1 Infection by Poordad, Fred, McCone, Jonathan, Bacon, Bruce R, Bruno, Savino, Manns, Michael P, Sulkowski, Mark S, Jacobson, Ira M, Reddy, K. Rajender, Goodman, Zachary D, Boparai, Navdeep, DiNubile, Mark J, Sniukiene, Vilma, Brass, Clifford A, Albrecht, Janice K, Bronowicki, Jean-Pierre

“…In this trial involving previously untreated patients infected with hepatitis C virus (HCV) genotype 1, boceprevir in combination with peginterferon and…”
Get full text

Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease by Ullmann, Andrew J, Lipton, Jeffrey H, Vesole, David H, Chandrasekar, Pranatharthi, Langston, Amelia, Tarantolo, Stefano R, Greinix, Hildegard, Morais de Azevedo, Wellington, Reddy, Vijay, Boparai, Navdeep, Pedicone, Lisa, Patino, Hernando, Durrant, Simon

“…This randomized, double-blind trial of prophylaxis to prevent invasive fungal infections was conducted in 600 patients with severe graft-versus-host disease…”
Get full text

Factors That Predict Response of Patients With Hepatitis C Virus Infection to Boceprevir by Poordad, Fred, Bronowicki, Jean–Pierre, Gordon, Stuart C, Zeuzem, Stefan, Jacobson, Ira M, Sulkowski, Mark S, Poynard, Thierry, Morgan, Timothy R, Molony, Cliona, Pedicone, Lisa D, Sings, Heather L, Burroughs, Margaret H, Sniukiene, Vilma, Boparai, Navdeep, Goteti, Venkata S, Brass, Clifford A, Albrecht, Janice K, Bacon, Bruce R

“…Background & Aims Little is known about factors associated with a sustained virologic response (SVR) among patients with hepatitis C virus (HCV) infection to…”
Get full text

Fixed-Dose Combination Therapy With Daclatasvir, Asunaprevir, and Beclabuvir for Noncirrhotic Patients With HCV Genotype 1 Infection by Poordad, Fred, Sievert, William, Mollison, Lindsay, Bennett, Michael, Tse, Edmund, Bräu, Norbert, Levin, James, Sepe, Thomas, Lee, Samuel S, Angus, Peter, Conway, Brian, Pol, Stanislas, Boyer, Nathalie, Bronowicki, Jean-Pierre, Jacobson, Ira, Muir, Andrew J, Reddy, K. Rajender, Tam, Edward, Ortiz-Lasanta, Grisell, de Lédinghen, Victor, Sulkowski, Mark, Boparai, Navdeep, McPhee, Fiona, Hughes, Eric, Swenson, E. Scott, Yin, Philip D

“…IMPORTANCE: The antiviral activity of all-oral, ribavirin-free, direct-acting antiviral regimens requires evaluation in patients with chronic hepatitis C virus…”
Get full text

Nonalcoholic fatty liver disease in patients with type 2 diabetes by Younossi, Zobair M, Gramlich, Terry, Matteoni, Christi A, Boparai, Navdeep, McCullough, Arthur J

“…Nonalcoholic fatty liver disease (NAFLD) is reported commonly in patients with type 2 diabetes mellitus (DM), which has been suggested as a risk factor for the…”
Get more information

Maintenance Therapy With Peginterferon Alfa-2b Does Not Prevent Hepatocellular Carcinoma in Cirrhotic Patients With Chronic Hepatitis C by Bruix, Jordi, Poynard, Thierry, Colombo, Massimo, Schiff, Eugene, Burak, Kelly, Heathcote, Elizabeth J.L, Berg, Thomas, Poo, Jorge–Luis, Mello, Carlos Brandao, Guenther, Rainer, Niederau, Claus, Terg, Ruben, Bedossa, Pierre, Boparai, Navdeep, Griffel, Louis H, Burroughs, Margaret, Brass, Clifford A, Albrecht, Janice K

“…Background & Aims Several studies have reported that low doses of interferon can delay the development of hepatocellular carcinoma (HCC) and progression of…”
Get full text

Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection by Zeuzem, Stefan, Hézode, Christophe, Bronowicki, Jean-Pierre, Loustaud-Ratti, Veronique, Gea, Francisco, Buti, Maria, Olveira, Antonio, Banyai, Tivadar, Al-Assi, M. Tarek, Petersen, Joerg, Thabut, Dominique, Gadano, Adrian, Pruitt, Ronald, Makara, Mihály, Bourlière, Marc, Pol, Stanislas, Beumont-Mauviel, Maria, Ouwerkerk-Mahadevan, Sivi, Picchio, Gaston, Bifano, Marc, M Phee, Fiona, Boparai, Navdeep, Cheung, Kin, Hughes, Eric A, Noviello, Stephanie

“…Graphical abstract…”
Get full text

Health-related quality of life in chronic liver disease: the impact of type and severity of disease by Younossi, Zobair M, Boparai, Navdeep, Price, Lori Lyn, Kiwi, Michelle L, McCormick, Marilyn, Guyatt, Gordon

“…The type and severity of chronic liver disease may have different effects on health-related quality of life (HRQL). The aim of our study was to determine…”
Get full text

Takayasu Arteritis Causing Aortitis and Aortic Regurgitation: A Totally Tubular Case Report by Boparai, Navdeep, Girgis, Mina, Kiamanesh, Omid, Al-Arnawoot, Amna, Amad, Hani, Tsang, Wendy

“…• Echocardiography is the first-line test to diagnose the presence and cause of AR. • Acute aortic syndromes should be excluded in patients with AR and a…”
Get full text

Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirin by Jacobson, Ira M., Marcellin, Patrick, Zeuzem, Stefan, Sulkowski, Mark S., Esteban, Rafael, Poordad, Fred, Bruno, Savino, Burroughs, Margaret H., Pedicone, Lisa D., Boparai, Navdeep, Deng, Weiping, DiNubile, Mark J., Gottesdiener, Keith M., Brass, Clifford A., Albrecht, Janice K., Bronowicki, Jean-Pierre

“…In comparison with peginterferon/ribavirin alone, boceprevir with peginterferon/ribavirin significantly improves sustained virological response (SVR) rates in…”
Get full text

Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity by Matteoni, Christi A., Younossi, Zobair M., Gramlich ‡, Terry, Boparai §, Navdeep, Liu ∥, Yao Chang, McCullough ¶, Arthur J.

“…Background & Aims: The spectrum of nonalcoholic fatty liver disease ranges from fatty liver alone to nonalcoholic steatohepatitis. Most previous studies have…”
Get full text

Risk factors for intracranial hemorrhage in adults on extracorporeal membrane oxygenation1 by Kasirajan, Vigneshwar, Smedira, Nicholas G., McCarthy, James F., Casselman, Filip, Boparai, Navdeep, McCarthy, Patrick M.

“…Objective. Intracranial hemorrhage is a recognized complication in neonates and infants on extracorporeal membrane oxygenator support and various risk factors…”
Get full text

Assessment of utilities and health-related quality of life in patients with chronic liver disease by Younossi, Zobair M, Boparai, Navdeep, McCormick, Marilyn, Price, Lori Lynn, Guyatt, Gordon

“…OBJECTIVES: Quantitative measures of the value patients place on the state of their health is crucial to understanding their experience, and to calculate…”
Get full text

Health-related quality of life in chronic liver disease: the impact of type and severity of disease by Younossi, Zobair M, Boparai, Navdeep, Price, Lori Lyn, Kiwi, Michelle L, McCormick, Marilyn, Guyatt, Gordon

“…OBJECTIVE: The type and severity of chronic liver disease may have different effects on health-related quality of life (HRQL). The aim of our study was to…”
Get full text

Case report: successful retreatment of hepatitis C genotype 1b infection with sofosbuvir + simeprevir in a patient with cirrhosis who had prior virologic relapse after treatment with daclatasvir and asunaprevir by Safadi, Rifaat, Noviello, Stephanie, Boparai, Navdeep, McPhee, Fiona

“…Key Clinical Message There is currently minimal clinical experience regarding retreatment options for patients failing direct‐acting antiviral combination…”
Get full text